First-line immune-chemotherapy combination for squamous NSCLC is already a reality

Lizza E.L. Hendriks, Jessica Menis, Jordi Remon

Résultats de recherche: Contribution à un journal › !!Comment/debate

1 Citation (Scopus)

langue originale	Anglais
Pages (de - à)	819-823
Nombre de pages	5
journal	Translational Lung Cancer Research
Volume	9
Numéro de publication	3
Les DOIs	https://doi.org/10.21037/tlcr.2020.03.36
état	Publié - 1 juin 2020
Modification externe	Oui

Accès au document

@article{1d737a3686404b34b588a8e92b44459d,

title = "First-line immune-chemotherapy combination for squamous NSCLC is already a reality",

author = "Hendriks, {Lizza E.L.} and Jessica Menis and Jordi Remon",

year = "2020",

month = jun,

day = "1",

doi = "10.21037/tlcr.2020.03.36",

language = "English",

volume = "9",

pages = "819--823",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

number = "3",

}

TY - JOUR

T1 - First-line immune-chemotherapy combination for squamous NSCLC is already a reality

AU - Hendriks, Lizza E.L.

AU - Menis, Jessica

AU - Remon, Jordi

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85090192445&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2020.03.36

DO - 10.21037/tlcr.2020.03.36

M3 - Comment/debate

AN - SCOPUS:85090192445

SN - 2218-6751

VL - 9

SP - 819

EP - 823

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

IS - 3

ER -